X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. A 45975
2. Adecur
3. Apo-terazosin
4. Deflox
5. Dysalfa
6. Flotrin
7. Heitrin
8. Hytrin
9. Hytrin Bph
10. Hytrine
11. Magnurol
12. Novo-terazosin
13. Nu-terazosin
14. Pms-terazosin
15. Ratio-terazosin
16. Sutif
17. Tazusin
18. Terazoflo
19. Terazosin
20. Terazosin Azu
21. Terazosin Hexal
22. Terazosin Hydrochloride Anhydrous
23. Terazosin, Monohydrochloride, Dihydrate
24. Terazosina Alter
25. Terazosina Kern
26. Terazosina Qualix
27. Zayasel
1. 63074-08-8
2. Terazosin Hcl
3. Hytrin
4. Fosfomic
5. Zayasel
6. Blavin
7. Terazosin Hydrochloride Anhydrous
8. Vasocard
9. (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone Hydrochloride
10. Flumarc
11. Mls000040261
12. Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, Monohydrochloride
13. Terazosin (hydrochloride)
14. 8qop8z9955
15. Terazocin Hydrochloride (anhydrous)
16. Smr000044015
17. Dsstox_cid_25493
18. Dsstox_rid_80913
19. Dsstox_gsid_45493
20. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine Hydrochloride
21. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine Hydrochloride
22. Abbott-45975 Anhydrous
23. Cas-63074-08-8
24. Sr-01000000197
25. Unii-8qop8z9955
26. Prestwick_146
27. Opera_id_398
28. Ncgc00016903-01
29. Schembl41545
30. Terazosin Hydrochloride,pharma
31. Mls001077301
32. Mls001305722
33. Chembl1256665
34. Dtxsid7045493
35. Hy-b0371f
36. Hms1570g04
37. Pharmakon1600-01505576
38. Bcp12795
39. Terazosin Hydrochloride [mi]
40. Tox21_110674
41. Mfcd00467965
42. Nsc759168
43. S4679
44. Akos007930686
45. Tox21_110674_1
46. Ac-2074
47. Ccg-220751
48. Lp01138
49. Ncgc00016026-10
50. Ncgc00094404-01
51. Ncgc00094404-02
52. Terazosin Hydrochloride, Anhydrous
53. Ds-11401
54. Db-018541
55. Cs-0013075
56. Eu-0101138
57. Ft-0605647
58. T2751
59. D11585
60. D70611
61. T 4680
62. Terazosin Hydrochloride, >=98% (tlc), Powder
63. 074t088
64. Terazosin Hydrochloride Anhydrous [who-dd]
65. Sr-01000000197-2
66. Sr-01000000197-4
67. Q27270906
68. Sr-01000000197-12
69. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)-piperazine Hydrochloride
70. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine Hydrochloride
71. 2[4-(tetrahydro-2-furoy1)piperazinyl]-4-amino-6,7-dimethoxyquinazoline Hydrochloride
72. 4-amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazoline Hydrochloride
73. (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanonehydrochloride
74. [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydrochloride
75. [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydron;chloride
76. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-piperazine Hydrochloride
77. Methanone, (4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl)(tetrahydro-2-furanyl)-, Hydrochloride (1:1)
78. Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, Monohydrochloride
| Molecular Weight | 423.9 g/mol |
|---|---|
| Molecular Formula | C19H26ClN5O4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 423.1673320 g/mol |
| Monoisotopic Mass | 423.1673320 g/mol |
| Topological Polar Surface Area | 103 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 544 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Terazosin hydrochloride |
| Drug Label | Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furan... |
| Active Ingredient | Terazosin hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | eq 5mg base; eq 2mg base; eq 1mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Jubilant Cadista; Apotex; Sandoz; Ivax Sub Teva Pharms; Mylan |
| 2 of 2 | |
|---|---|
| Drug Name | Terazosin hydrochloride |
| Drug Label | Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furan... |
| Active Ingredient | Terazosin hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | eq 5mg base; eq 2mg base; eq 1mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Jubilant Cadista; Apotex; Sandoz; Ivax Sub Teva Pharms; Mylan |
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Adrenergic alpha-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)
Market Place
